Nephrol Dial Transplant (2002) 17: 7-10
© 2002 European Renal Association-European Dialysis and Transplant Association
Editorial Comments
Dismal long-term survival of dialysis patients after acute myocardial infarction: can we alter the outcome?
Hennepin County Medical Center, Minneapolis, MN, USA
The burden of ischemic heart disease in end-stage renal disease
Cardiac disease is the major cause of death in dialysis patients, accounting for about 45% of all-cause mortalities [1]. Approximately 20% of cardiac deaths are attributed to acute myocardial infarction (AMI) [1]. In the United States, the greatest increase in treated end-stage renal disease (ESRD) has occurred in patients with the highest risk for cardiovascular disease, older patients and those with diabetic nephropathy. There were an estimated 281 000 dialysis patients in 2000, with a projected number of 520 000 U.S. dialysis patients by 2010 [2]. The burden of ischaemic heart disease in ESRD patients has been confirmed by the European Dialysis and Transplant Association (EDTA) registry. In the United Kingdom, the all-age death rate from myocardial ischaemia and AMI for patients commencing renal replacement therapy in 1985 to 1990 was 16.6-fold greater in men and 17.7-fold greater in women, compared to the general
The pathogenesis of vascular lessions
Mortality of dialysis and cardiac death
Mortality of acute myocardial infarction in the patient on dialysis or after renal transplantation
Are dialysis patients given optimal treatment after acute myocardial infarcation?
Can we alter the outcome?
Notes
References
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Liberek, A. Warzocha, M. Chmielewski, and B. Rutkowski Initiation of dialysis--the right timing and the right tools Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3895 - 3896. [Full Text] [PDF]
|
|
|
|
|
|
S. Sawhney, O. Djurdjev, K. Simpson, A. Macleod, and A. Levin Reply Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3896 - 3896. [Full Text] [PDF]
|
|
|
|
|
|
A. Kramer, V. Stel, C. Zoccali, J. Heaf, D. Ansell, C. Gronhagen-Riska, T. Leivestad, K. Simpson, R. Palsson, M. Postorino, et al. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006 Nephrol. Dial. Transplant., December 1, 2009; 24(12): 3557 - 3566. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. S. Stel, F. W. Dekker, D. Ansell, H. Augustijn, F. G. Casino, F. Collart, P. Finne, G. A. Ioannidis, M. Salomone, J. P. Traynor, et al. Residual renal function at the start of dialysis and clinical outcomes Nephrol. Dial. Transplant., October 1, 2009; 24(10): 3175 - 3182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Pedrini, A. Feliciani, S. Zerbi, G. Cozzi, and P. Ruggiero Optimization of mid-dilution haemodiafiltration: technique and performance Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2816 - 2824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Berger and P. J.M. Best Does Kidney Function Alter the Benefit of Reperfusion Therapy for ST-Segment Elevation Myocardial Infarction? J. Am. Coll. Cardiol. Intv., January 1, 2009; 2(1): 34 - 36. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ronco, M. Haapio, A. A. House, N. Anavekar, and R. Bellomo Cardiorenal Syndrome J. Am. Coll. Cardiol., November 4, 2008; 52(19): 1527 - 1539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Almond, S. Siddiqui, S. Robertson, J. Norrie, and C. Isles Comparison of combined urea and creatinine clearance and prediction equations as measures of residual renal function when GFR is low QJM, August 1, 2008; 101(8): 619 - 624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Locatelli, C. Zoccali, and SIR SIN Study Investigators Clinical policies on the management of chronic kidney disease patients in Italy Nephrol. Dial. Transplant., February 1, 2008; 23(2): 621 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Risch, H. Drexel, and A. R. Huber Differences in Glomerular Filtration Rate Estimates by 2 Cystatin C-Based Equations Clin. Chem., November 1, 2005; 51(11): 2211 - 2212. [Full Text] [PDF]
|
|
|
|
|
|
A. R. Huber and L. Risch Recent Developments in the Evaluation of Glomerular Filtration Rate: Is There a Place for {beta}-Trace? Clin. Chem., August 1, 2005; 51(8): 1329 - 1330. [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Parekh, L. Zhang, B. A. Fivush, and M. J. Klag Incidence of Atherosclerosis by Race in the Dialysis Morbidity and Mortality Study: A Sample of the US ESRD Population J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1420 - 1426. [Abstract] [Full Text] [PDF]
|
|